[Primary cervical choriocarcinoma of the uterine cervix]. 2005

J F Peko, and S Buambo

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D002822 Choriocarcinoma A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL). Choriocarcinomas
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D018997 Chorionic Gonadotropin, beta Subunit, Human The beta subunit of human CHORIONIC GONADOTROPIN. Its structure is similar to the beta subunit of LUTEINIZING HORMONE, except for the additional 30 amino acids at the carboxy end with the associated carbohydrate residues. HCG-beta is used as a diagnostic marker for early detection of pregnancy, spontaneous abortion (ABORTION, SPONTANEOUS); ECTOPIC PREGNANCY; HYDATIDIFORM MOLE; CHORIOCARCINOMA; or DOWN SYNDROME. HCG-beta,Human Chorionic Gonadotropin, beta Subunit,Chorionic Gonadotropin, beta Chain, Human,Chorionic Gonadotropin, beta Polypeptide, Human,HCG, beta Subunit,HCG beta

Related Publications

J F Peko, and S Buambo
April 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
J F Peko, and S Buambo
July 1993, Geburtshilfe und Frauenheilkunde,
J F Peko, and S Buambo
January 2022, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society,
J F Peko, and S Buambo
January 1988, Zentralblatt fur Gynakologie,
J F Peko, and S Buambo
September 1988, Asia-Oceania journal of obstetrics and gynaecology,
J F Peko, and S Buambo
October 1961, Minerva ginecologica,
J F Peko, and S Buambo
July 2005, Gynecologic oncology,
J F Peko, and S Buambo
January 1994, Journal de gynecologie, obstetrique et biologie de la reproduction,
J F Peko, and S Buambo
September 2003, Gynecologic oncology,
Copied contents to your clipboard!